Brain Stimulation for Working Memory Issues
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new treatment called intermittent Theta Burst Stimulation (iTBS) to determine its effectiveness in improving working memory issues in teenagers with ADHD. The study examines how this brain stimulation affects areas involved in memory processes and aims to identify the best treatment targets. It includes both active and sham (inactive) treatment sessions for comparison. Teens aged 12-18 years with working memory problems and an ADHD diagnosis may be suitable candidates for this trial. Participants will receive compensation, and joining the trial does not require changes to existing medical care. As an unphased trial, this study offers participants a unique opportunity to contribute to groundbreaking research and potentially benefit from innovative treatment.
Will I have to stop taking my current medications?
The trial does not require changes to your current medications unless you are taking medications that lower the seizure threshold, which may exclude you from participating. Psychostimulant medications are allowed if deemed safe by the medical review process.
What prior data suggests that this brain stimulation technique is safe for adolescents?
Research has shown that intermittent theta burst stimulation (iTBS) is generally safe. Studies have found that iTBS can enhance thinking skills, such as memory and attention, in individuals with mild memory problems and other conditions. This suggests that iTBS could be safe for teenagers with memory challenges.
One study found that iTBS helped individuals with mild memory issues and early Alzheimer's disease think more clearly. Another study showed that iTBS might improve focus and task management in people with depression.
No major reports of serious side effects have emerged with iTBS, indicating its safety. Individuals considering participation in an iTBS trial can feel confident about its safety based on these findings.12345Why are researchers excited about this trial?
Researchers are excited about intermittent Theta Burst Stimulation (iTBS) for working memory issues because it offers a novel and non-invasive approach to brain stimulation. Unlike standard treatments, which might include medications or cognitive therapies, iTBS directly targets and stimulates specific brain areas, such as the dorsolateral prefrontal cortex or inferior parietal lobule. This treatment aims to enhance brain activity associated with working memory by using rhythmic bursts of magnetic pulses, potentially improving cognitive function more quickly and effectively than traditional methods. Additionally, its precision in targeting brain regions based on individual brain imaging sets it apart from more generalized approaches.
What evidence suggests that this trial's treatments could be effective for working memory issues?
Research has shown that intermittent theta burst stimulation (iTBS) might improve working memory issues. Some studies found that iTBS can enhance cognitive skills, particularly in individuals with mild memory problems or those recovering from a stroke. In this trial, participants will receive either active iTBS or sham iTBS through random assignment. iTBS sends quick bursts of magnetic energy to the brain, promoting change and adaptation. This treatment has also shown promise in other conditions, such as depression and ADHD, by targeting specific brain areas involved in memory and attention.678910
Are You a Good Fit for This Trial?
This trial is for adolescents aged 13-17 with an IQ over 80 and diagnosed ADHD, who struggle with working memory. They must be fluent in English, able to consent (with parental permission), and have a parent-reported BRIEF-2 Working Memory score above the norm. Exclusions include certain neurological conditions, metal implants affecting the brain or spinal cord, active psychosis or mania, current pregnancy, substance abuse within six months, and other specific medical criteria.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive intermittent theta burst stimulation (iTBS) at the left dorsolateral prefrontal cortex (DLPFC) or inferior parietal lobule (IPL) with both active and sham sessions
Follow-up
Participants are monitored for changes in theta-gamma coupling and working memory performance after iTBS sessions
What Are the Treatments Tested in This Trial?
Interventions
- Active Intermittent Theta Burst Stimulation
- Intermittent Theta Burst Stimulation
- Sham Intermittent Theta Burst Stimulation
Intermittent Theta Burst Stimulation is already approved in United States, European Union for the following indications:
- Treatment-resistant depression
- Treatment-resistant depression
Find a Clinic Near You
Who Is Running the Clinical Trial?
Bradley Hospital
Lead Sponsor